| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.5 | 0.3 |
| Gross profit | 0.2 | 0.2 |
| Profit before tax | -0.1 | 0.1 |
| Net income | -0.1 | 0.1 |
| EPS (diluted, $ a share) | $-0.00 | $0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +36.8% |
|---|---|
| Gross margin | 48.6% |
| Operating margin | -8.6% |
10-Q filed with the SEC, OTC: ADIA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Adia Med, Inc.: key numbers
- Share price
- $0.1280Close, Nov 13
- Market cap
- $12.1M
- Shares outstanding
- 94.4MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Adia Med, Inc.
All →Adia Med Divestiture to Larry A. Powalisz
Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell a 7% membership interest in its subsidiary, Adia Labs LLC, to the company's CEO, Larry A. Powalisz. The transaction is valued at $350,000 in cash, with the use of proceeds restricted to corporate purposes jointly approved by the company's independent directors.
- Counterparty
- Larry A. Powalisz
Adia Med $935K Debt Financing with Larry Powalisz
Adia Med, Inc. fully repaid and discharged its $1.0 million unsecured revolving line of credit facility with its CEO, Larry Powalisz. The company made two payments totaling $934,970.94, which included $74,658.94 in accrued interest, to satisfy the debt in full. This related-party facility, originally entered into in June 2024, is now terminated following the final payment on October 9, 2026.
- Value
- $935K
- Counterparty
- Larry Powalisz
Adia Med Divestiture to Live Oak Health LLC for $1.5M
Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell a 30% interest in its subsidiary, Adia Labs LLC, to Live Oak Health LLC (dba QCM Biologics) for $1.5 million. The consideration consists of $1.0 million in cash and a $0.5 million promissory note, with the buyer also receiving an option to purchase an additional 10% stake for $0.5 million. Despite the minority equity sale, the agreement establishes equal 50/50 voting power between Adia Med and the buyer regarding member matters.
- Value
- $1.5M
- Counterparty
- Live Oak Health LLC
Adia Med Court & Legal Update
Adia Med, Inc. filed a declaratory judgment lawsuit in Florida against Tydus Richards and other purported shareholders to quiet title in 29,059,792 shares of common stock. The company alleges the shares, representing approximately 30.78% of its outstanding stock, were never validly issued or paid for. If successful, the action would allow the company to cancel and retire these shares, significantly reducing its total share count.
- Counterparty
- Tydus Richards